Physician
Ruleman, Vicky
Ruleman, Vicky was paid $1.25M by Medicaid between Feb 2018 and Mar 2023, across 39 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoRULEMAN, VICKY
PEABODY, MA 01960
PEABODY, MA 01960
33aNPI1366862955assigned 04/22/2014
33bProvider typePediatrics Physician
28Total paid$1.25M
24GClaims35,277
24DCodes billed39
24AFirst – last monthFeb 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#64 of 1,273
Median peer was paid$24K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,490 | $151K | |
| 2019 | 5,656 | $198K | |
| 2020 | 5,994 | $201K | |
| 2021 | 8,905 | $306K | |
| 2022 | 8,140 | $312K | |
| 2023 | 2,092 | $86K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 2,634 | 2,532 | $255K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 3,453 | 3,375 | $189K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 4,571 | 3,778 | $161K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.6% | 1,288 | 1,288 | $107K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.5% | 1,356 | 1,349 | $106K |
| 90461 | 5.4% | 1,788 | 1,778 | $67K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.9% | 1,199 | 1,183 | $62K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.1% | 621 | 621 | $51K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.1% | 4,248 | 4,240 | $38K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.9% | 3,004 | 2,984 | $36K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.7% | 461 | 460 | $34K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 1,026 | 1,007 | $27K |
27 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 728 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 2,379 | $17K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 159 | $14K |
| 96127 | <1% | 1,197 | $12K | |
| 99177 | <1% | 687 | $10K | |
| 36416 | <1% | 926 | $9K | |
| 99188 | <1% | 324 | $8K | |
| 99050 | <1% | 303 | $5K | |
| 80061 | Lipid panel | <1% | 346 | $4K |
| 83655 | <1% | 357 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 128 | $3K |
| 81003 | <1% | 800 | $2K | |
| 0001A | <1% | 28 | $1K | |
| 99051 | <1% | 73 | $1K | |
| 0071A | <1% | 26 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 42 | $992.04 |
| 36415 | Collection of venous blood by venipuncture | <1% | 436 | $970.35 |
| 94760 | <1% | 353 | $763.51 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 58 | $684.98 |
| 0081A | <1% | 12 | $550.56 | |
| 83718 | <1% | 40 | $338.00 | |
| 87081 | <1% | 31 | $212.04 | |
| 92587 | <1% | 13 | $207.72 | |
| 82465 | <1% | 40 | $179.20 | |
| 87807 | <1% | 13 | $153.53 | |
| 99000 | <1% | 117 | $117.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 12 | $2.90 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.